| Financial Year |
March 31 2023 |
| Monetary Funds |
153,000,505.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,187,190.44 |
| Accounts Receivable |
1,427,083,922.32 |
| Advances to Suppliers |
16,590,896.73 |
| Other Receivables |
22,367,109.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,986,735.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
77,493,210.55 |
| Other Current Assets |
30,774,688.88 |
| Total Current Assets |
2,355,340,680.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,685,960,204.58 |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,705,171.47 |
| Fixed Assetes |
3,799,800.03 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,322,383.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
613,772.79 |
| Deferred Income Tax Assets |
54,305,923.53 |
| Other Non-Current Assets |
50,676,796.30 |
| Sub-Total of Non-Current Assets |
1,829,965,174.51 |
| Total Assets |
4,185,305,854.97 |
| Short-Term Loans |
308,094,834.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,164,250.00 |
| Accounts Payable |
850,282,022.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,159,739.91 |
| Taxes Payable |
2,201,289.24 |
| Interest Payable |
-- |
| Dividend Payable |
53,800.00 |
| Other payables |
46,207,904.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,420,238.73 |
| Other Current Liabilities |
185,571,180.70 |
| Sub-Total of Current Liabilities |
1,601,728,349.79 |
| Long-term Loans |
913,886,739.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
65,022,263.32 |
| Sub-Total of Non-Current Liabilities |
990,963,650.49 |
| Total Liabilities |
2,592,692,000.28 |
| Paid-In Capital(Or Share Stock) |
211,697,778.00 |
| Capital Surplus |
855,325,629.49 |
| Surplus Reserve |
77,748,650.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
312,823,063.41 |
| Minority Stockholder's Interest |
135,018,732.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,457,595,121.77 |
| Owner's Equity（Stockholder's Equity） |
1,592,613,854.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,185,305,854.97 |
